136 related articles for article (PubMed ID: 38402501)
1. A multi-center randomized controlled trial to investigate potential effects of exercise therapy on renal function stratified by renal disorders and renal pathology: beneficial or harmful effect in immunoglobulin a nephropathy.
Kimura T; Washida N; Ohtsuki S; Sugita K; Hosoya K; Uchiyama K
Clin Exp Nephrol; 2024 Jun; 28(6):539-546. PubMed ID: 38402501
[TBL] [Abstract][Full Text] [Related]
2. Agreement between cystatin-C and creatinine based eGFR estimates after a 12-month exercise intervention in patients with chronic kidney disease.
Beetham KS; Howden EJ; Isbel NM; Coombes JS
BMC Nephrol; 2018 Dec; 19(1):366. PubMed ID: 30563479
[TBL] [Abstract][Full Text] [Related]
3. Effect of exercise training on estimated GFR, vascular health, and cardiorespiratory fitness in patients with CKD: a pilot randomized controlled trial.
Greenwood SA; Koufaki P; Mercer TH; MacLaughlin HL; Rush R; Lindup H; O'Connor E; Jones C; Hendry BM; Macdougall IC; Cairns HS
Am J Kidney Dis; 2015 Mar; 65(3):425-34. PubMed ID: 25236582
[TBL] [Abstract][Full Text] [Related]
4. Renal Morphology, Clinical Findings, and Progression Rate in Mesoamerican Nephropathy.
Wijkström J; González-Quiroz M; Hernandez M; Trujillo Z; Hultenby K; Ring A; Söderberg M; Aragón A; Elinder CG; Wernerson A
Am J Kidney Dis; 2017 May; 69(5):626-636. PubMed ID: 28126239
[TBL] [Abstract][Full Text] [Related]
5. Creatinine- and cystatin C-based estimated glomerular filtration rate slopes for the prediction of kidney outcome: a comparative retrospective study.
Kim S; Hwang S; Jang HR; Sohn I; Ahn HS; Park HD; Huh W; Jin DC; Kim YG; Kim DJ; Oh HY; Lee JE
BMC Nephrol; 2019 Jun; 20(1):214. PubMed ID: 31185945
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of chronic kidney diseases in patients with chronic obstructive pulmonary disease: assessment based on glomerular filtration rate estimated from creatinine and cystatin C levels.
Yoshizawa T; Okada K; Furuichi S; Ishiguro T; Yoshizawa A; Akahoshi T; Gon Y; Akashiba T; Hosokawa Y; Hashimoto S
Int J Chron Obstruct Pulmon Dis; 2015; 10():1283-9. PubMed ID: 26185434
[TBL] [Abstract][Full Text] [Related]
7. The prognostic role of heart rate recovery after exercise and metabolic syndrome in IgA nephropathy.
Sági B; Késői I; Vas T; Csiky B; Nagy J; Kovács T
BMC Nephrol; 2021 Nov; 22(1):390. PubMed ID: 34809611
[TBL] [Abstract][Full Text] [Related]
8. Cystatin C- and creatinine-based estimated glomerular filtration rate, vascular disease, and mortality in persons with diabetes in the U.S.
Tsai CW; Grams ME; Inker LA; Coresh J; Selvin E
Diabetes Care; 2014 Apr; 37(4):1002-8. PubMed ID: 24271191
[TBL] [Abstract][Full Text] [Related]
9. Performance of cystatin C- and creatinine-based estimated glomerular filtration rate equations depends on patient characteristics.
Meeusen JW; Rule AD; Voskoboev N; Baumann NA; Lieske JC
Clin Chem; 2015 Oct; 61(10):1265-72. PubMed ID: 26240296
[TBL] [Abstract][Full Text] [Related]
10. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
Li S; Li JP
Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
[TBL] [Abstract][Full Text] [Related]
11. The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study.
Shardlow A; McIntyre NJ; Fraser SDS; Roderick P; Raftery J; Fluck RJ; McIntyre CW; Taal MW
PLoS Med; 2017 Oct; 14(10):e1002400. PubMed ID: 29016597
[TBL] [Abstract][Full Text] [Related]
12. Twelve-week combined resistance and aerobic training confers greater benefits than aerobic training alone in nondialysis CKD.
Watson EL; Gould DW; Wilkinson TJ; Xenophontos S; Clarke AL; Vogt BP; Viana JL; Smith AC
Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1188-F1196. PubMed ID: 29412705
[TBL] [Abstract][Full Text] [Related]
13. Oral calcitriol for reduction of proteinuria in patients with IgA nephropathy: a randomized controlled trial.
Liu LJ; Lv JC; Shi SF; Chen YQ; Zhang H; Wang HY
Am J Kidney Dis; 2012 Jan; 59(1):67-74. PubMed ID: 22019331
[TBL] [Abstract][Full Text] [Related]
14. Chronic kidney disease progression to end stage renal disease: a single center experience of the role of the underlying kidney disease.
Ekart R; Ferjuc A; Furman B; Gerjevič Š; Bevc S; Hojs R
Ther Apher Dial; 2013 Aug; 17(4):363-7. PubMed ID: 23931872
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive therapy in patients with IgA nephropathy.
Peters HP; van den Brand JA; Berger SP; Wetzels JF
Neth J Med; 2015 Jul; 73(6):284-9. PubMed ID: 26228193
[TBL] [Abstract][Full Text] [Related]
16. Pathological spectrum of glomerular disease in patients with renal insufficiency: a single-center study in Northeastern China.
Chen L; Luodelete M; Dong C; Li B; Zhang W; Nie P; Liu J; Chen X; Luo P
Ren Fail; 2019 Nov; 41(1):473-480. PubMed ID: 31198075
[No Abstract] [Full Text] [Related]
17. Effects of home-based exercise on pre-dialysis chronic kidney disease patients: a randomized pilot and feasibility trial.
Hiraki K; Shibagaki Y; Izawa KP; Hotta C; Wakamiya A; Sakurada T; Yasuda T; Kimura K
BMC Nephrol; 2017 Jun; 18(1):198. PubMed ID: 28623895
[TBL] [Abstract][Full Text] [Related]
18. Physical Activity In Renal Disease (PAIRED) and the effect on hypertension: study protocol for a randomized controlled trial.
Thompson S; Wiebe N; Gyenes G; Davies R; Radhakrishnan J; Graham M
Trials; 2019 Feb; 20(1):109. PubMed ID: 30736832
[TBL] [Abstract][Full Text] [Related]
19. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y
BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312
[TBL] [Abstract][Full Text] [Related]
20. Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized and controlled pilot study.
Leehey DJ; Moinuddin I; Bast JP; Qureshi S; Jelinek CS; Cooper C; Edwards LC; Smith BM; Collins EG
Cardiovasc Diabetol; 2009 Dec; 8():62. PubMed ID: 20003224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
